Accessibility Skip to:
  • Accessibility Policy
  • Main Content
  • Main Menu
  • Contact

  • -A: Font Smaller
  • +A: Font Larger
  • Reset Font
  • High Contrast
  • Low Contrast
  • Reset Contrast
History:
You are here:
  • Grand Challenges Canada
  • >
  • Innovations
  • >
  • 1807-13599
  • Français
  • Get to Know Us
    • Who We Are
    • Co-CEOs
    • Governance
    • Accountability
    • The Team
    • Partnerships
    • Career Opportunities
    • Service Opportunities
    • Contact Us
  • Learn What We Do
    • What We Do
    • Global Health Innovation
    • Humanitarian
    • Indigenous
    • Transition To Scale
    • Innovative Financing
    • Innovations & Results
    • Annual Report
  • Apply for Funding
    • Funding Opportunities
    • Innovator Resources
    • Gender Equality Portal
  • Get Informed
    • News and Media
    • Blog
    • Publications
    • Subscribe
    • Photos and Videos
Grand Challenges Canada

Bold Ideas with Big Impact®

Browse our Innovations and Results
  • Get to Know Us
    • Who We Are
    • Co-CEOs
    • Governance
    • Accountability
    • The Team
    • Partnerships
    • Career Opportunities
    • Service Opportunities
    • Contact Us
  • Learn What We Do
    • What We Do
    • Global Health Innovation
    • Humanitarian
    • Indigenous
    • Transition To Scale
    • Innovative Financing
    • Innovations & Results
    • Annual Report
  • Apply for Funding
    • Funding Opportunities
    • Innovator Resources
    • Gender Equality Portal
  • Get Informed
    • News and Media
    • Blog
    • Publications
    • Subscribe
    • Photos and Videos
  • Accessibility
  • Contact
  • Français

Home » Innovations » 1807-13599

Integrating chlorhexidine 7.1% into safe delivery kit in Republic of South Sudan: A low cost intervention to reduce neonatal mortality in rural community settings

Health newborn as result of CHX application

Health newborn as result of CHX application

FacebookTwitterLinked In

Start Date: 31/03/2018- End Date: 31/03/2019


Project Lead(s): Christopher Vunni Draiko

Issue

The number of newborn deaths in South Sudan has consistently increased in recent years, culminating in a mortality rate of 40% in 2018. 20% of these newborn deaths were attributed to sepsis due to cord infections during birth.

The majority of the newborns at risk come from families of low socio-economic status (SES) in rural settings. These families often live in poverty and lack the resources needed for neonatal care. Mothers are often forced to deliver their babies under the care of family members and Traditional Birth Attendants (TBAs) in a home rather than a hospital, creating a risky delivery environment.

Chlorohexidine (CHX) gel has been recommended for cord infection prevention, but has not been utilized in South Sudan.

Solution

The Better Health Care Organization in South Sudan integrated CHX gel into Safe Delivery Kits (SDKs) for mothers giving birth in hygienically challenging environments. The aim of the CHX Safe Delivery Kit intervention was to prevent cord infections by: increasing the availability of safe delivery tools and creating a hygienic environment for mothers giving birth at home.

The project specifically targeted communities with high rates of home births, infections, and newborn deaths. In 3 communities, the project collaborated with local health workers, Community Health Workers (CHWs), and traditional birth attendants. Overall, 100 CHWs and 20 health workers were trained on how to use CHX gel to prevent cord infections.

Community awareness campaigns on the importance of using CHX gel were conducted, and SDKs were distributed through CHWs.

 Outcome

The project demonstrated that a 7-day application of CHX gel reduces cord infections and, subsequently, newborn mortality.

In total, 1,034 neonates received cord treatment using CHX gel. The neonatal mortality rate plummeted from the national average of 20%, to just 4% in the intervention group. Overall, 82% of neonates were infection-free after birth, despite the fact 78% of births during the intervention took place in a hygiene constrained environment.

Newborns who received CHX gel were followed for 28 days. The innovators found that CHX gel, along with hand washing and clean delivery, replaced some of the rudimentary and harmful traditional practices within the community.

As a result of this project, health workers, mothers, and CHWs were better equipped to prevent future newborn cord infections.

The project obtained $61,200 through an in-kind donation and $75,000 in NGO funding. They are now looking to partner with the government of South Sudan.

Image Gallery

  • Health newborn as result of CHX application
  • Healthy Newborn Who benefited from Clean Delivery and Cord apllication
  • CHW being Shown how to
  • Innovative Product  and Training Materials
  • Project Team Providing Comunity Awareness
  • Home Follow Up
  • CHW afer completing Training on Innovative Product
  • Training of CHW on Inoovative Product
  • BHECO_ Presetation at Confernce on CHXSDK innovations
  • Mother and her newborn Babies  happy with no Cord infections
  • Better Health Care Organization 1
  • CHW _ Providing Health Education on Innovative Product

Stay in touch with this innovator

  • Facebook
  • Twitter
  • Organization Website
  • Innovation Overview
    Program

    Stars in Global Health

    Institution

    Better Health Care Organization

    Institution Country

    South Sudan

    Implementation Country

    South Sudan

    Implementation Region

    Sub-Saharan Africa

    Priority

    Intrapartum-related complications, Maternal Conditions, Newborn Conditions, Sepsis, Skilled birth attendants

    Platform

    Drug, Service Delivery, Supply chain management

  • @BetterHealthCa3

    Grand Challenges Canada’s programs are primarily undertaken with the financial support of the Government of Canada provided through Global Affairs Canada.

    Government of Canada
    • Fluxx Technical Support
    • Privacy Policy
    • Website Legal Terms and Disclaimer
    We use cookies on our website to give you the most relevant experience by remembering your preferences and activity on our website. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may click on "Cookie Settings" to select the cookies applicable to your activity and disable those that do not. Please note that you will not be able to disable all cookies as some are necessary for the functioning of the website.
    Cookie Settings Accept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    Save & Accept